skip to main content
Close Icon We use cookies to improve your website experience.  To learn about our use of cookies and how you can manage your cookie settings, please see our Cookie Policy.  By continuing to use the website, you consent to our use of cookies.
Informa pharma logo

Pharma Intelligence is part of the Business Intelligence Division of Informa PLC

This is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

PharmaLogo
Search Icon Pharma Report StoreRecommendationsProduct loginProductLogin
Global Search Configuration

Refine Results

Clear All

Specialism

Show More

Resources

Show More

Show More

Products

Show More

Show More

1125 Total results for product and free and sample content found

Sitetrove

Sitetrove Roundup

13 Dec 2018

Find the right investigators and sites for your clinical trials. For the pharma industry’s most accurate and comprehensive investigator and site intelligence, turn to the invaluable data in Sitetrove. Sitetrove’s team of expert analysts continuously scour over 43,000 public sources to update curated information on the global clinical trial landscape, with content tailored to specific therapeutic areas. Save time and avoid costly delays: find the right investigators in the geographic areas that suit your needs with Sitetrove.

Topic Clinical trials Clinical trial optimization

View infographic

Pink Sheet

Getting Worse Not Better: UK Report On Access To Cancer Drugs

05 Dec 2018

A UK report on patient access to cancer drugs suggests that the European Medicines Agency could learn from the US Food and Drug Administration and best practice elsewhere in the world when it comes to taking a faster, more flexible approach to assessing evidence.

Topic Cancer

View article

In Vivo

Medical Aesthetics: A Untapped Pharma Market With Incoming Competition

By Mandy Jackson 05 Dec 2018

Medical aesthetics is a unique biopharmaceutical niche that may scare off companies due to the consumer marketing and doctor relationship-building skills needed to compete in this market, but the potential for growth keeps major players engaged and searching for new technology.

Topic BioPharmaceutical

View article

Medtech Insight

EU Regulatory Roundup November 2018

By Amanda Maxwell 05 Dec 2018

The medtech sector was already quite overwhelmed with the new EU regulations and Brexit uncertainties. Now add into the mix the impact of the global journalistic Implant Files investigation.

Topic Brexit Medtech

View article

Medtech Insight

FDA Device Panel Delivers Thumbs Up For Breakthrough Heart-Failure Device

By Elizabeth Orr 05 Dec 2018

A US FDA panel overwhelmingly supported a heart-failure device designed to use cardiac contractility modulation to improve heart function. The Optimizer Smart system from Impulse Dynamics is apparently the first in FDA’s Breakthrough Devices program to go before an advisory panel.

Topic FDA

View article

Scrip

No, It's Not Just Out-Of-Pocket Costs That Are A Problem, John Arnold Tells Pharma

By Jessica Merrill 05 Dec 2018

The billionaire philanthropist and industry agitator took the stage at the Forbes Healthcare Summit to discuss why his foundation is focused on fixing drug pricing and supporting organizations like ICER and Patients for Affordable Drugs.

Topic Drug approval Drug development landscape Drug review

View article

Scrip

Imbruvica Replaces Chemo, Darzalex Boosts Standard Of Care In Front-Line CLL, Myeloma

By Mandy Jackson 05 Dec 2018

Late-breaker presentations at ASH showed that replacing chemotherapy agents with Imbruvica in CLL, and adding Darzalex to Revlimid and dexamethasone in multiple myeloma, is more effective than current standards of care in certain front-line settings.

Topic Cancer Drug approval

View article

Scrip

AI-Driven Drug Development Seen Blossoming In Korea As Govt Lends Support

By Jung Won Shin 05 Dec 2018

Application of artificial intelligence to new drug development in South Korea, which has been lagging in this area, is poised to accelerate as the country moves to support and encourage the technology.

Topic Drug development landscape Drug review

View article

Datamonitor Healthcare

Gene Therapy: A Paradigm Shift in Medicine

By Amanda Micklus 30 Nov 2018

The following analysis reviews several aspects of the gene therapy market. The history of gene therapy is briefly discussed, alongside a look at the trend in the volume of candidates in development over the past 20+ years, and how the regulatory landscape in the US and EU has recently adapted to help move the field forward. A deep dive into the pipeline with  breakdowns by delivery method and therapy area is provided, as are the key companies involved and the major partnership deals that have made gene therapy a hot commodity. Manufacturing, pricing, and reimbursement issues are also addressed.

Topic Cell and gene therapy

View white paper
Show More

Next steps

Getting a demo tailored to your needs is the best way to see how our solutions will help you gain an advantage.

Request live demo now:

Request a free demo

Our team is always happy to hear from you. Please call us at:

  • US Toll-Free  : +1 888 670 8900
  • US Toll           : +1 908 547 2200
  • UK & Europe : +44 (20) 337 73737
  • Australia        : +61 2 8705 6907
  • Japan              : +81 3 6273 4260

Or please submit your inquiry via the form so that we can provide you the best possible customer service.
General enquiry

Have an immediate and specific information need?

Browse and buy from 1000s of analysis and research reports now:

Shop now